A full service drug test is a drug testing package that covers every step of the process, from specimen collection and laboratory analysis to medical review of the results. Unlike a simple point-of-care screening (the kind done with a cup and test strip), full service testing sends your sample to a certified lab, confirms any positive results with a second, more precise test, and has a licensed physician review the findings before they reach your employer. Most workplace drug testing programs, especially those regulated by the federal government, follow this full service model.
What “Full Service” Actually Includes
The term describes a complete chain of services rather than a specific panel of drugs. A full service drug test typically bundles three core layers: supervised specimen collection at an authorized site, laboratory analysis using a two-step testing method, and a final review by a Medical Review Officer (MRO). Many programs also include a Third-Party Administrator that handles scheduling, random selection pools, and compliance tracking on behalf of the employer.
When employers advertise “full service drug testing,” they’re distinguishing their program from a rapid or instant test. Rapid tests give a preliminary result in minutes but carry a higher risk of false positives. A full service approach uses those rapid-style immunoassay screens as only the first step, then routes anything that flags positive to a confirmation test using gas chromatography-mass spectrometry or liquid chromatography-mass spectrometry. These instruments identify the exact compounds in a sample, essentially eliminating false positives from cross-reacting medications or foods.
Which Drugs Are Tested
The specific panel depends on the employer and whether federal regulations apply. DOT-regulated testing (for truck drivers, pilots, pipeline workers, and similar safety-sensitive roles) requires a standard five-category panel: marijuana, cocaine, opiates, amphetamines and methamphetamines, and PCP. As of July 2025, updated federal guidelines add fentanyl and MDMA (ecstasy) to the mandatory panel for federal workplace programs, reflecting the current drug landscape.
Private employers not bound by DOT rules often choose broader panels. A 10-panel test is one of the most common and covers marijuana, cocaine, opioids (including heroin, oxycodone, hydrocodone, and fentanyl), benzodiazepines (like Xanax, Valium, and Klonopin), amphetamines (including ADHD medications like Adderall), barbiturates, PCP, MDMA, methaqualone, and propoxyphene. Some employers go further with 12-panel or custom panels that add synthetic opioids or other substances relevant to their industry. Under non-DOT programs, employers can also choose specimen types beyond urine, such as hair or oral fluid.
How the Collection Works
Collection follows a strict protocol designed to prevent tampering and hold up legally. At the collection site, you’ll present identification and the collector will complete a Custody and Control Form (CCF) that tracks your specimen from the moment you provide it to the moment a lab technician opens it. The collector checks the temperature of a urine sample within four minutes and notes any unusual appearance. You watch the collector pour your specimen into labeled bottles, seal them, and apply tamper-evident labels that you then initial.
If a split specimen collection is ordered, your sample is divided into two bottles. The primary bottle (Bottle A) goes through standard testing. The second bottle (Bottle B) is stored so you can request an independent retest at a different lab if your result comes back positive.
For hair testing, a collector typically takes a small sample close to the scalp. Oral fluid collections involve placing an absorbent pad between your cheek and gum for a few minutes. Each specimen type has its own chain of custody requirements, all documented on that same CCF.
Detection Windows by Specimen Type
One reason employers choose certain specimen types over others is the detection window. Urine testing catches drug use within roughly 1 to 3 days for most substances, though heavy marijuana use can remain detectable for weeks. Oral fluid (saliva) is best for identifying very recent use, generally within the past 1 to 36 hours. Hair testing offers the longest window at 7 to 100 or more days, making it useful when an employer wants a broader look at a person’s drug use history. Sweat patches, used less commonly, can monitor continuously over 1 to 14 days.
Most full service programs default to urine because it balances detection window, cost, and regulatory acceptance. DOT programs require urine, though updated federal guidelines now authorize oral fluid as an alternative for some federal workplace programs.
The Two-Step Lab Process
Once your specimen arrives at a certified laboratory, it goes through an initial immunoassay screen. This is a fast, relatively inexpensive test that identifies samples above a set concentration threshold. For marijuana metabolites in urine, for example, the federal cutoff is 50 ng/mL on the initial screen. Anything below that threshold is reported as negative and the process ends there.
Samples that screen positive move to confirmatory testing. The lab uses gas chromatography-mass spectrometry or liquid chromatography-mass spectrometry to identify and measure the exact drug compounds present. Confirmatory cutoffs are typically lower than initial screen cutoffs. Marijuana confirmation, for instance, drops to 15 ng/mL. Cocaine metabolite confirmation drops from 150 to 100 ng/mL. This two-step design ensures that quick screening catches potential positives cheaply while confirmation testing eliminates false results before anything reaches a reviewer.
What the Medical Review Officer Does
The MRO is a licensed physician trained specifically in drug testing interpretation. Their role is the final safeguard against a legitimate prescription being reported as a failed test. When a lab reports a confirmed positive, the MRO contacts you directly, usually within 24 hours. During that call, they ask whether you have a medical explanation for the result.
If you claim a prescribed medication caused the positive, you’ll need to provide documentation: a copy of the prescription, the pharmacy label, or a medical record showing valid use. The MRO may call your prescribing doctor or pharmacist to verify. If the prescription checks out, the MRO changes the result to negative and that’s what your employer sees. They never learn which medication you take. If there’s no valid medical explanation, the MRO reports the positive result to the employer.
This entire review process can take up to two weeks when verification is needed. Negative results, which require no MRO interview, typically reach the employer within a few business days.
DOT vs. Non-DOT Programs
DOT testing follows rigid federal rules under 49 CFR Part 40. The drug panel is fixed, the specimen must be urine (with oral fluid now being phased in), the lab must be federally certified, and every step from collection to MRO review follows a prescribed sequence. DOT also mandates alcohol testing at a breath alcohol concentration threshold of 0.02 or greater.
Non-DOT programs give employers much more flexibility. They can test for additional drugs, use hair or oral fluid instead of urine, set their own cutoff levels, and design policies around state laws (which vary widely on issues like marijuana testing). Employers can run a DOT-compliant program for regulated employees and a separate, broader company program for everyone else. The key requirement is that the two programs remain clearly distinct in policy documents and record-keeping.
Typical Turnaround Times
For a negative result where nothing flags on the initial screen, most full service programs deliver results to the employer in 1 to 3 business days. If the initial screen triggers a confirmation test, add another 1 to 2 days of lab time. A result that requires MRO review extends the timeline further. The MRO must attempt to contact you, conduct an interview, and potentially verify prescriptions. Each step has built-in waiting periods, so a positive result that ultimately gets downgraded to negative through valid prescription documentation can take up to two weeks from collection to final report.
If you’re waiting on results for a job offer, a negative screen moves quickly. Any delay beyond a few days usually signals that the lab found something requiring confirmation or that the MRO is trying to reach you. Answering that MRO call promptly is the single most effective thing you can do to speed up the process.